Comment
. 2010 Sep;40(9):1431-2; author reply 1432.
doi: 10.1111/j.1365-2222.2010.03579.x.
Sublingual immunotherapy affects transforming growth factor-beta and nasal eosinophils
- PMID: 20701617
- DOI: 10.1111/j.1365-2222.2010.03579.x
Item in Clipboard
Comment
Sublingual immunotherapy affects transforming growth factor-beta and nasal eosinophils
Clin Exp Allergy.
2010 Sep.
No abstract available
Comment on
-
Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells.Clin Exp Allergy. 2010 Apr;40(4):598-606. doi: 10.1111/j.1365-2222.2010.03462.x. Epub 2010 Feb 22. Clin Exp Allergy. 2010. PMID: 20184605 Clinical Trial.
Similar articles
-
The impact of immunotherapy on the pathophysiology of ragweed pollen allergy.Rhinol Suppl. 1992;14:52-6. Rhinol Suppl. 1992. PMID: 1389403 No abstract available.
-
IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy.J Allergy Clin Immunol. 2005 Jul;116(1):73-9. doi: 10.1016/j.jaci.2005.03.011. J Allergy Clin Immunol. 2005. PMID: 15990777 Clinical Trial.
-
Serum transforming growth factor-beta levels depend on allergen exposure in allergic rhinitis.Int Arch Allergy Immunol. 2010;152(1):66-70. doi: 10.1159/000260085. Epub 2009 Nov 24. Int Arch Allergy Immunol. 2010. PMID: 19940507
-
Sublingual immunotherapy.N Engl J Med. 2008 May 22;358(21):2259-64. doi: 10.1056/NEJMct0708337. N Engl J Med. 2008. PMID: 18499568 Review. No abstract available.
-
Short review on sublingual immunotherapy for patients with allergic rhinitis: from bench to bedside.Adv Otorhinolaryngol. 2011;72:103-6. doi: 10.1159/000324631. Epub 2011 Aug 18. Adv Otorhinolaryngol. 2011. PMID: 21865703 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
